dacarbazine has been researched along with Disease, Pulmonary in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (8.00) | 18.7374 |
| 1990's | 6 (24.00) | 18.2507 |
| 2000's | 7 (28.00) | 29.6817 |
| 2010's | 10 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atenafu, EG; Crump, M; Kukreti, V; Kuruvilla, J; Marras, TK; Sun, HL; Tsang, R | 1 |
| Ansell, SM; Connors, JM; Fanale, M; Park, SI; Younes, A | 1 |
| Behringer, K; Böll, B; Borchmann, P; Borchmann, S; Bröckelmann, PJ; Bürkle, C; Diehl, V; Eichenauer, DA; Engert, A; Fuchs, M; Goergen, H; Greil, R; Hitz, F; Kerkhoff, A; von Tresckow, B | 1 |
| Chong, G; Doig, R; Grigg, A; Ha, FJ; Hamid, A; Hawkes, EA; Jalali, A; Mckendrick, J; Schwarer, AP | 1 |
| Bonfante, V; Busia, A; Laffranchi, A; Villani, F; Villani, M; Viviani, S | 1 |
| Cunningham, D; Hancock, BW; Horwich, A; Hoskin, PJ; Jack, A; Johnson, PW; Linch, D; Lowry, L; Mead, B; Patrick, P; Pettengell, R; Pettitt, A; Popova, B; Qian, W; Smith, P; Sweetenham, J | 1 |
| Bonfante, V; Busia, A; Laffranchi, A; Villani, F; Viviani, S | 1 |
| Dib, M; Gagnadoux, F; Paris, A; Rousselet, MC; Tazi, A; Urban, T | 1 |
| Ambinder, RF; Gladstone, DE; Gocke, CD; Habermann, TM; Herman, JM; Jacene, HA; Jones, RJ; Kasamon, YL; Link, BK; Matsui, WH; Perkins, B; Popplewell, LL; Swinnen, LJ | 1 |
| Chuang, HH; Copeland, AR; Dabaja, BS; Dang, N; Fanale, MA; Fayad, LE; Feng, L; Goy, A; Hagemeister, F; Kwak, LW; Macapinlac, HA; McLaughlin, P; Neelapu, SS; Oki, Y; Pro, B; Rodriguez, MA; Romaguera, J; Samaniego, F; Younes, A; Yuan, Y | 1 |
| Boro, J; Cheung, MC; Ezzat, HM; Harris, M; Hicks, LK; Leitch, HA; Lima, VD; Montaner, JS | 1 |
| Advani, R; Bartlett, NL; Cheson, BD; Connors, JM; Evens, AM; Fisher, RI; Gascoyne, RD; Gordon, LI; Gospodarowicz, M; Hong, F; Hoppe, RT; Horning, SJ; Kahl, BS; Miller, TP; Stiff, PJ; Wagner, H | 1 |
| Goy, A; Moskowitz, C; Myers, J; Noy, A; Portlock, CS; Qin, J; Straus, DJ; Yahalom, J; Zelenetz, AD | 1 |
| Garipidou, V; Kaloutsi, V; Perifanis, V; Tziomalos, K; Vakalopoulou, S; Zafiriadou, E | 1 |
| Ansell, SM; Colgan, JP; Habermann, TM; Martin, WG; Ristow, KM; Witzig, TE | 1 |
| Arcaini, L; Baio, A; Brusamolino, E; Casagrande, W; Franchini, P; Griva, V; Lazzarino, M; Orlandi, E; Pascutto, C; Passamonti, F | 1 |
| Diehl, V; Fuchs, M | 1 |
| Harker, WG; Kushlan, P; Rosenberg, SA | 1 |
| Arico, M; Baio, A; Bossi, G; Cerveri, I; Corbella, F; Corsico, A; Klersy, C; Volpini, E | 1 |
| Berd, D; De Potter, P; Mastrangelo, MJ; Nathan, FE; Sato, T; Shield, JA; Shields, CL | 1 |
| Polliack, A; Putterman, C | 1 |
| Lerud, KS; Luetkehans, TJ; Shanley, DJ | 1 |
| Boiron, M; Brice, P; Ferme, C; Frija, J; Gisselbrecht, C; Hennequin, C; Marolleau, JP; Monsuez, JJ; Tredaniel, J | 1 |
| Antman, KH; Elias, A | 1 |
| Bonadonna, G; Bonfante, V; Crippa, F; Musumeci, R; Pagnoni, AM; Santoro, A; Valagussa, P; Villani, F; Viviani, S; Zucali, R | 1 |
2 review(s) available for dacarbazine and Disease, Pulmonary
| Article | Year |
|---|---|
Will BEACOPP be the standard for high risk Hodgkin lymphoma patients in advanced stages?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Heart Diseases; Hodgkin Disease; Humans; Infertility; Lung Diseases; Mechlorethamine; Multicenter Studies as Topic; Neoplasm Staging; Neoplasms, Second Primary; Prednisone; Procarbazine; Risk; Survival Rate; Vinblastine; Vincristine | 2007 |
Late cardiovascular and pulmonary complications of therapy in Hodgkin's disease: report of three unusual cases, with a review of relevant literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cardiovascular Diseases; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Lung Diseases; Middle Aged; Radiation Injuries; Radiotherapy; Splenectomy; Vinblastine; Vincristine | 1992 |
10 trial(s) available for dacarbazine and Disease, Pulmonary
| Article | Year |
|---|---|
Five-year follow-up of brentuximab vedotin combined with ABVD or AVD for advanced-stage classical Hodgkin lymphoma.
Topics: Adolescent; Adult; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Dacarbazine; Disease-Free Survival; Doxorubicin; Drug Interactions; Female; Follow-Up Studies; Hodgkin Disease; Humans; Immunoconjugates; Kaplan-Meier Estimate; Lung Diseases; Male; Middle Aged; Molecular Targeted Therapy; Remission Induction; Treatment Outcome; Vinblastine; Young Adult | 2017 |
Bleomycin in older early-stage favorable Hodgkin lymphoma patients: analysis of the German Hodgkin Study Group (GHSG) HD10 and HD13 trials.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Female; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Lung Diseases; Male; Middle Aged; Neoplasm Staging; Remission Induction; Vinblastine | 2016 |
Randomized comparison of the stanford V regimen and ABVD in the treatment of advanced Hodgkin's Lymphoma: United Kingdom National Cancer Research Institute Lymphoma Group Study ISRCTN 64141244.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Lung Diseases; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Treatment Outcome; Vinblastine; Young Adult | 2009 |
Phase 2 study of rituximab-ABVD in classical Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocyte Subsets; Bleomycin; Clone Cells; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Epstein-Barr Virus Infections; Fatigue; Female; Gastrointestinal Diseases; Herpesvirus 4, Human; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Lung Diseases; Male; Middle Aged; Neutropenia; Remission Induction; Rituximab; Survival Rate; Vinblastine; Young Adult | 2012 |
Phase 2 study of rituximab plus ABVD in patients with newly diagnosed classical Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Alopecia; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Fatigue; Female; Gastrointestinal Diseases; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Lung Diseases; Male; Middle Aged; Neutropenia; Remission Induction; Rituximab; Survival Rate; Vinblastine; Young Adult | 2012 |
The efficacy and tolerability of adriamycin, bleomycin, vinblastine, dacarbazine and Stanford V in older Hodgkin lymphoma patients: a comprehensive analysis from the North American intergroup trial E2496.
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Etoposide; Female; Hematologic Diseases; Hodgkin Disease; Humans; Lung Diseases; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednisone; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine | 2013 |
Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) followed by radiation therapy (RT) versus ABVD alone for stages I, II, and IIIA nonbulky Hodgkin disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Leukopenia; Lung Diseases; Male; Middle Aged; Neoplasm Staging; Radiotherapy, Adjuvant; Remission Induction; Survival Analysis; Vinblastine | 2004 |
BOLD+interferon in the treatment of metastatic uveal melanoma: first report of active systemic therapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Female; Humans; Interferon alpha-2; Interferon-alpha; Lomustine; Lung Diseases; Male; Melanoma; Middle Aged; Recombinant Proteins; Uveal Neoplasms; Vincristine | 1997 |
Dana-Farber Cancer Institute studies in advanced sarcoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Central Nervous System Diseases; Child; Child, Preschool; Combined Modality Therapy; Dacarbazine; Doxorubicin; Drug Administration Schedule; Female; Heart Diseases; Humans; Ifosfamide; Lung Diseases; Male; Mesna; Middle Aged; Randomized Controlled Trials as Topic; Sarcoma; Survival Analysis; Urologic Diseases | 1990 |
Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin's disease: superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Genital Diseases, Female; Genital Diseases, Male; Heart Diseases; Hodgkin Disease; Humans; Lung Diseases; Male; Mechlorethamine; Neoplasm Staging; Prednisone; Procarbazine; Random Allocation; Statistics as Topic; Vinblastine; Vincristine | 1987 |
13 other study(ies) available for dacarbazine and Disease, Pulmonary
| Article | Year |
|---|---|
Bleomycin pulmonary toxicity does not adversely affect the outcome of patients with Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Lung Diseases; Male; Middle Aged; Outcome Assessment, Health Care; Proportional Hazards Models; Retrospective Studies; Vinblastine; Young Adult | 2017 |
Hodgkin lymphoma: an Australian experience of ABVD chemotherapy in the modern era.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Australia; Bleomycin; Chemotherapy-Induced Febrile Neutropenia; Combined Modality Therapy; Dacarbazine; Databases, Factual; Disease-Free Survival; Doxorubicin; Female; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Lung Diseases; Male; Medical Records; Middle Aged; Neoplasm Staging; Radiotherapy, Adjuvant; Retrospective Studies; Treatment Outcome; Vinblastine; Young Adult | 2016 |
Cardiopulmonary response to exercise in patients with different degrees of lung toxicity after radio-chemotherapy for Hodgkin's disease.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cardiovascular Diseases; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Epirubicin; Etoposide; Exercise; Female; Hodgkin Disease; Humans; Lung Diseases; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Radiation Injuries; Vinblastine; Vincristine; Young Adult | 2009 |
Cardiopulmonary toxicity of different chemoradiotherapy combined regimens for Hodgkin's disease.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cardiovascular Diseases; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Epirubicin; Etoposide; Female; Hodgkin Disease; Humans; Lung Diseases; Male; Mechlorethamine; Middle Aged; Oxygen Consumption; Prednisone; Procarbazine; Radiation Injuries; Radiotherapy; Vinblastine; Vincristine; Young Adult | 2010 |
[Pulmonary Langerhans histiocytosis and Hodgkin's lymphoma].
Topics: Accidents, Traffic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bronchioles; Carmustine; Cytarabine; Dacarbazine; Doxorubicin; Etoposide; Female; Histiocytosis, Langerhans-Cell; Hodgkin Disease; Humans; Ifosfamide; Incidental Findings; Lung Diseases; Lymphatic Diseases; Marijuana Smoking; Melphalan; Methylprednisolone; Mitoguazone; Remission Induction; Smoking; Tomography, X-Ray Computed; Vinblastine; Vindesine; Vinorelbine; Young Adult | 2011 |
Incidence, predictors and significance of severe toxicity in patients with human immunodeficiency virus-associated Hodgkin lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Bleomycin; Dacarbazine; Doxorubicin; Female; Hematologic Diseases; HIV Infections; HIV Protease Inhibitors; Hodgkin Disease; Humans; Incidence; Kaplan-Meier Estimate; Lopinavir; Lung Diseases; Male; Mechlorethamine; Middle Aged; Nervous System Diseases; Prednisone; Procarbazine; Prognosis; Retrospective Studies; Ritonavir; Vinblastine; Vincristine | 2012 |
Uncommon manifestation of bleomycin-induced pulmonary toxicity in a patient with Hodgkin's disease.
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Inflammation; Lung Diseases; Syndrome; Tomography, X-Ray Computed; Vinblastine | 2005 |
Bleomycin pulmonary toxicity has a negative impact on the outcome of patients with Hodgkin's lymphoma.
Topics: Adolescent; Adult; Age Distribution; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Lung Diseases; Male; Middle Aged; Neoplasm Staging; Risk Factors; Survival Rate; Treatment Outcome; Vinblastine | 2005 |
Long-term events in adult patients with clinical stage IA-IIA nonbulky Hodgkin's lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-up.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cardiovascular Diseases; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Fertility; Follow-Up Studies; Hodgkin Disease; Humans; Lung Diseases; Male; Middle Aged; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Pregnancy; Radiotherapy, Adjuvant; Survival Analysis; Vinblastine | 2006 |
Combination chemotherapy for advanced Hodgkin's disease after failure of MOPP: ABVD and B-CAVe.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Drug Resistance; Female; Heart Diseases; Hodgkin Disease; Humans; Lomustine; Lung Diseases; Male; Mechlorethamine; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Procarbazine; Vinblastine; Vincristine | 1984 |
Long-term pulmonary sequelae after treatment of childhood Hodgkin's disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Combined Modality Therapy; Cross-Sectional Studies; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lung; Lung Diseases; Male; Mechlorethamine; Prednisone; Procarbazine; Radiotherapy; Respiratory Function Tests; Vinblastine; Vincristine | 1997 |
Development of pulmonary histiocytosis X after chemotherapy for Hodgkin disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Histiocytosis, Langerhans-Cell; Hodgkin Disease; Humans; Lung Diseases; Mechlorethamine; Prednisone; Procarbazine; Vinblastine; Vincristine | 1990 |
Cardiopulmonary toxicity after three courses of ABVD and mediastinal irradiation in favorable Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Echocardiography; Electrocardiography; Female; Heart Diseases; Hodgkin Disease; Humans; Lung Diseases; Male; Middle Aged; Neoplasm Staging; Radiation Injuries; Radiography; Radiotherapy Dosage; Respiratory Function Tests; Stroke Volume; Vinblastine; Vincristine | 1991 |